deltatrials
Terminated PHASE1 INTERVENTIONAL 2-arm NCT03935815

Quadratus Lumborum Nerve Blocks for Myomectomies

Quadratus Lumborum Nerve Blocks in Laparoscopic Myomectomy Patients

Sponsor: University of California, Los Angeles

Conditions Laparoscopic Myomectomy Quadratus Lumborum Nerve Block
Interventions Ropivacaine injection Sham treatment
Updated 6 times since 2019 Last updated: Apr 26, 2021 Started: May 1, 2019 Primary completion: Jun 6, 2020 Completion: Jun 8, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Closed prior to completion secondary to surgeon leaving UCLA

Other terminated trials from University of California, Los Angeles

See all terminations from University of California, Los Angeles

Other Laparoscopic Myomectomy trials with similar outcome

Browse all Laparoscopic Myomectomy trials

A PHASE1 clinical study on Laparoscopic Myomectomy and Quadratus Lumborum Nerve Block, this trial is terminated or withdrawn. The trial is conducted by University of California, Los Angeles and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshotRecruiting~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshotRecruiting~Jan 2021 – ~May 2021 · 4 months · monthly snapshotRecruiting~May 2021 – ~Jul 2024 · 38 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. May 2021 — Jul 2024 [monthly]

    Terminated PHASE1

    Status: Recruiting → Terminated

  4. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE1

  5. Sep 2019 — Jan 2021 [monthly]

    Recruiting PHASE1

▶ Show 1 earlier version

  1. Jun 2019 — Sep 2019 [monthly]

    Recruiting PHASE1

    First recorded

May 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of California, Los Angeles
Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations